Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease

Area of Science:

• Neuroscience
• Cell Biology
• Gerontology

Background:

• Late-onset Alzheimer's disease (LOAD) etiology remains unknown, accounting for over 95% of AD cases.
• Cellular senescence is implicated in AD pathophysiology, but mechanisms of brain cell senescence and its role are unclear.

Purpose of the Study:

• Investigate the role of plasminogen activator inhibitor 1 (PAI-1) in brain cell senescence and LOAD.
• Determine if senescent astrocytes contribute to neurodegeneration via secreted factors.

Main Methods:

• Analyzed PAI-1, p53, and p21 expression in SAMP8 mice and LOAD patients.
• Utilized in vitro studies with primary astrocytes to assess PAI-1's role in senescence.
• Examined the impact of conditioned medium from senescent astrocytes on neuronal apoptosis.

Main Results:

• PAI-1 expression correlated with p53 and p21 in LOAD brains and SAMP8 mice.
• Overexpressing PAI-1 induced astrocyte senescence; inhibiting PAI-1 reduced senescence.
• Conditioned medium from senescent astrocytes induced neuron apoptosis, with PAI-1 being a key secreted factor.

Conclusions:

• Increased PAI-1 contributes to brain cell senescence in LOAD.
• Senescent astrocytes promote neuron apoptosis through secreting factors like PAI-1.
• PAI-1 is a potential therapeutic target for LOAD.